[1]崔钦娜, 李芳, 邢伟越. 铜绿假单胞菌全局调控因子 RsmA 的缺失影响 2 个吩嗪基因簇的表达[J]. 微生物学报, 2012, 52(11):1326-1334. [2]黄兴富, 范华. 铜绿假单胞菌的临床分布及对环丙沙星耐药机制的研究[J]. 中国实验诊断, 2013, 18(3):437-440. [3]徐立升, 刘明涛, 张芸, 等. 抗菌药联合外排泵抑制剂对铜绿假单胞菌耐药突变选择窗的影响[J]. 中华医学杂志, 94(26):2055-2058. [4]朱玉莹, 易勇, 杨犀. 多重耐药铜绿假单胞菌中Ⅰ型整合子新结构的发现及其与耐药的相关性[J]. 微生物学报, 2013, 53(9):927-932. [5] Loots K, Revets H, Goddeeris BM. Attachment of the outer membrane lipoprotein(OprI)of Pseudomonas aeruginosa to the mucosal surfaces of the respiratory and digestive tract of chickens[J]. Vaccine, 2008, 26(4):546-551. [6]Weimer ET, Ervin SE, Wozniak DJ, et al. Immunization of young African green monkeys with OprF epitope 8-OprI-type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa[J]. Vaccine, 2009, 27(48):6762-6769. [7]Rahner R, Eckhardt A, Duchêne M, et al. Protection of immunosuppressed mice against infection with pseudomonas aeruginosa by monoclonal antibodies to outer membrane protein OprI[J]. Infection, 1990, 18(4):242-245. [8]Rau H, Revets H, Cornelis P, et al. Efficacy and functionality of lipoprotein OprI from Pseudomonas aeruginosa as adjuvant for a subunit vaccine against classical swine fever[J]. Vaccine, 2006, 24(22):4757-4768. [9]von Specht BU, Lücking HC, Blum B, et al. The Pseudomonas aeruginosa outer membrane protein I vaccine:immunogenicity and safe administration in man[J]. Behring Inst Mitt, 1997, 98:326-337. [10] Westritschnig K, Hochreiter R, Wallner G, et al. A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein OprF/I vaccine(IC43)in healthy volunteers[J]. Human Vaccines & Immunotherapeutics, 2014, 10(1):170-183. [11]刘祥, 陈春琳, 牟欢, 等. 重组人骨硬化蛋白的表达、纯化及多克隆抗体制备[J]. 生物技术, 2014, 24(6):68-72. [12]刘祥. 溶藻弧菌附着定值因子ACFA原核载体构建、表达条件优化及多克隆抗体制备[J]. 华北农学报, 2015, 30(1):35-41. [13]Stryjewska A, Kiepura K, Librowski T, et al. Biotechnology and genetic engineering in the new drug development. Part II monoclonal antibodies, modern vaccines and gene therapy[J]. Pharmacological Reports, 2013, 65(5):1086-1101. [14]Zhang L, Cai D, Zhao X, et al. Liposomes containing recombinant gp85 protein vaccine against ALV-J in chickens[J]. Vaccine, 2014, 32(21):2452-2456. [15]Tripathi NK, Priya R, Shrivastava A. Production of recombinant Chikungunya virus envelope 2 protein in Escherichia coli[J]. Applied Microbiology and Biotechnology, 2014, 98(6):2461-2471. [16] Xu M, Sun Q, Su J. Microbial transformation of geniposide in Gardenia jasminoides Ellis into genipin by Penicillium nigricans[J]. Enzyme and Microbial Technology, 2008, 42(5):440-444. [17]Corrales-Garcia L, Ortiz E, Casta?eda-Delgado J, et al. Bacterial expression and antibiotic activities of recombinant variants of human β-defensins on pathogenic bacteria and M. tuberculosis[J]. Protein Expression and Purification, 2013, 89(1):33-43. [18]Studier FW. Protein production by auto-induction in high density shaking cultures[J]. Protein Expression and Purification, 2005, 41(1):207-234. |